CSF-based biomarkers relevant to parkinsonism and cognitive decline include alpha-synuclein (α-syn), beta-amyloid-42 (Aβ42), total-tau (t-tau), phosphorylated-tau (p-tau), and neurofilament light (NfL) [9]. This evidence concerns the gene MAPT and Parkinson disease.